Thermo Fisher Scientific Inc

0.00 (0.0%)


Draw Mode:

Volume 0
Bid Price
Ask Price
News -
Day High


52 Week Range


Day Low
Company Name Stock Ticker Symbol Market Type
Thermo Fisher Scientific Inc TMO NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 515.25 20:00:00
Open Price Low Price High Price Close Price Prev Close
Trades Volume Avg Volume 52 Week Range
0 0 - 475.77 - 611.06
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 515.25 USD

Thermo Fisher Scientific Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 198.74B 385.72M 384.94M $ 10.71B $ 12.85M 3.34 33.30
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.27% 06/14/23 -8.70k -

more financials information »

Thermo Fisher Scientific News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No TMO Message Board. Create One! See More Posts on TMO Message Board See More Message Board Posts

Historical TMO Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week523.49527.16512.60518.401,819,989-8.24-1.57%
1 Month523.02534.64498.50518.371,770,325-7.77-1.49%
3 Months555.31593.17498.50541.521,478,267-40.06-7.21%
6 Months562.11609.85498.50553.271,449,208-46.86-8.34%
1 Year547.93611.06475.77545.591,409,094-32.68-5.96%
3 Years350.08672.34330.57519.431,479,325165.1747.18%
5 Years217.63672.34202.83421.131,496,374297.62136.76%

Thermo Fisher Scientific Description

Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, life science reagents and provides drug testing and manufacturing services. The firm operates through four segments (revenue figures include some cross-segment revenue and adjustments are made for the PPD acquisition and the deceleration of COVID-19 testing revenue): analytical technologies (15% of sales); specialty diagnostic products (14%); life science solutions (27%); and lab products and services (52%).